Literature DB >> 24816986

In situ hybridization analysis of the temporospatial expression of the midkine/pleiotrophin family in rat embryonic pituitary gland.

Ken Fujiwara1, Rita Maliza, Alimuddin Tofrizal, Khongorzul Batchuluun, Dini Ramadhani, Takehiro Tsukada, Morio Azuma, Kotaro Horiguchi, Motoshi Kikuchi, Takashi Yashiro.   

Abstract

Pituitary gland development is controlled by numerous signaling molecules, which are produced in the oral ectoderm and diencephalon. A newly described family of heparin-binding growth factors, namely midkine (MK)/pleiotrophin (PTN), is involved in regulating the growth and differentiation of many tissues and organs. Using in situ hybridization with digoxigenin-labeled cRNA probes, we detected cells expressing MK and PTN in the developing rat pituitary gland. At embryonic day 12.5 (E12.5), MK expression was localized in Rathke's pouch (derived from the oral ectoderm) and in the neurohypophyseal bud (derived from the diencephalon). From E12.5 to E19.5, MK mRNA was expressed in the developing neurohypophysis, and expression gradually decreased in the developing adenohypophysis. To characterize MK-expressing cells, we performed double-staining of MK mRNA and anterior pituitary hormones. At E19.5, no MK-expressing cells were stained with any hormone. In contrast, PTN was expressed only in the neurohypophysis primordium during all embryonic stages. In situ hybridization clearly showed that MK was expressed in primitive (immature/undifferentiated) adenohypophyseal cells and neurohypophyseal cells, whereas PTN was expressed only in neurohypophyseal cells. Thus, MK and PTN might play roles as signaling molecules during pituitary development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816986     DOI: 10.1007/s00441-014-1875-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  2 in total

1.  Age-associated changes in gene expression in the anterior pituitary glands of female Japanese black cattle.

Authors:  Dimas Arya Abdillah; Onalenna Kereilwe; Yoichi Mizukami; Kenji Watanabe; Hiroya Kadokawa
Journal:  Mamm Genome       Date:  2022-07-15       Impact factor: 3.224

Review 2.  Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial.

Authors:  Diego Caicedo; Pablo Devesa; Clara V Alvarez; Jesús Devesa
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.